ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      0.00%
      US Tech 100
      19,213.60
      1.07%
      Dow Jones
      40,287.53
      0.00%
      Brent Oil
      81.155
      -1.37%
      Bitcoin
      67,676.57
      -0.70%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Oasmia Pharmaceuticals AB (OASM)

      7. Oasmia Pharmaceuticals AB (OASM) Financials

      Oasmia Pharmaceuticals AB

      Oasmia Pharmaceuticals AB (OASM)

      NASDAQ
      1.55
      0.00
      (0.00%)
      Closed July 19 4:00PM
      Delayed by 15 minutes
      1.55
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Oasmia Pharmaceuticals AB Financial Summary

      The current OASM market cap is 833.97M. The company's latest EPS is SEK -0.2393 and P/E is -21.77.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
      Total Revenue 1.68M1.02M264k1.03M7.21M
      Operating Income -31.04M-21.54M-28.84M-16.57M-65.23M
      Net Income -30.03M-20.43M-28.17M-15.78M-64.36M
      Year End December 30 2023 20202020202120222023
      SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
      Total Revenue 201.95M2.76M68.48M4.68M9.5M
      Operating Income -30.41M-131.7M-128.84M-364.35M-132.2M
      Net Income -10.53M-140.27M-132.72M-365.72M-128.74M

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
      Total Assets 545.92M330.33M306.93M283.48M220.67M
      Total Liabilities 30.45M25.35M30.14M22.31M22.87M
      Total Equity 515.47M304.98M276.8M261.17M197.8M
      Year End December 30 2023 20202020202120222023
      SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
      Total Assets 1.01B863.54M594.31M355.88M220.67M
      Total Liabilities 185.96M183.35M44.6M30.45M22.87M
      Total Equity 819.39M680.2M549.71M325.42M197.8M

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
      Operating -80.25M-23.27M-39.75M-58.45M-68.74M
      Investing -45.28M19.79M35.55M55.81M63.73M
      Financing 128.76M-1.04M-1.92M-2.81M N/A
      Year End December 30 2023 20202020202120222023
      SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
      Operating -6.87M-136.58M-145.57M-80.52M-68.74M
      Investing -288.12M-14.37M118.65M-45.28M63.73M
      Financing 379.72M-4.01M-5.81M128.76M N/A

      Stats and Ratios

      Market Cap 833.97M
      Price to Earnings Ratio -21.77
      Price to Sales Ratio 294.35
      Price to Cash Ratio 651.25
      Price to Book Ratio 14.17
      Dividend Yield -

      Share Statistics

      Shares Outstanding 538.04M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 1.13 (52.8%)

      Company Info

      Company Name Oasmia Pharmaceuticals AB
      Address vallongatan 1
      uppsala SE-752 28
      Website https://www.vivesto.com
      Industry pharmaceutical preparations (2834)